MENTA CAPITAL LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 181 filers reported holding HAEMONETICS CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MENTA CAPITAL LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2018$427,000
+1.4%
3,725
-35.3%
0.15%
+67.4%
Q1 2018$421,000
-27.7%
5,760
-42.5%
0.09%
-21.2%
Q4 2017$582,000
-53.1%
10,025
-63.7%
0.11%
-37.9%
Q3 2017$1,240,000
-37.9%
27,625
-45.4%
0.18%
-23.2%
Q2 2017$1,996,000
+50.0%
50,551
+10.1%
0.24%
+29.5%
Q2 2016$1,331,000
+177.9%
45,900
+235.0%
0.18%
+177.3%
Q1 2016$479,000
-29.5%
13,700
-34.8%
0.07%
-38.3%
Q3 2015$679,00021,0190.11%
Other shareholders
HAEMONETICS CORP shareholders Q3 2016
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders